With Ikaria and Aptalis, Private Equity Investors Get Creative To Cash Out
This article was originally published in The Pink Sheet Daily
Executive Summary
Ikaria shareholders sold the commercial side of that critical care business, but retained a stake in the off-loaded assets. While gastrointestinal and cystic fibrosis company Aptalis turns to an IPO instead of an acquisition.